Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

I missed the part where the analysts reduced the net present value of the shares by 50% for the “clown management” effect. Maybe that’s because it doesn’t exist. All of the analyst previous reports that I read simply discounted the future projected revenue, and that is what they did now. In fact, I have never seen an analyst report reduce a price target based on “clown management.” Let’s face it, these guys pull their price estimates out of the ether. Odd that analysts predict a value of $250m for ADXS, assuming approval, whereas KITE, with one approved product, is worth $12 billion. I’ve got a bridge in Brooklyn to sell to anyone who believes this is accurate.